Alyeska Investment Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-25,266
Closed -$579K 281
2013
Q3
$579K Sell
25,266
-10,454
-29% -$240K 0.02% 235
2013
Q2
$633K Buy
+35,720
New +$633K 0.03% 217